Refine by
Tissue Damage Suppliers In Australia
4 companies found
based inEumundi, AUSTRALIA
The trauma that current methods of nasotracheal intubation can cause to the patient’s nasal passage is extensive, and the complexity of this technique for medical professionals can be frustrating, particularly in emergency trauma situations. The ...
This novel innovation offers the benefits of a simpler, safer and more predictable nasal endotracheal intubation method. ...
based inPaddington, AUSTRALIA
Regeneus is an Australian biotechnology company aiming to improve the quality of life of the hundreds of millions of patients worldwide suffering from long and short term pain. Pain and inflammation are responsible for a series of events leading to ...
Progenza is a cryopreserved multi-synergistic therapy targeting pain and inflammation. Regeneus has patented techniques and high-quality testing to ensure the production of millions of Progenza™ doses from a single donor ...
based inBrunswick, AUSTRALIA
Avania is an integrated global, full-service CRO with specialized expertise in medical device, novel technology, and combination products. They advance products from feasibility all the way through post-approval trials in analytics, clinical trials, ...
Although skin is the largest organ of the human body, it takes a team with specialized knowledge to successfully advance dermatology trials. We collaborate with you to ensure your dermatology trial starts on the right track, delving into the details ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
Revascor is a Phase 3 product candidate being developed as a treatment for both advanced and end-stage chronic heart failure ...